Published in Kidney Int on November 01, 1999
Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am J Pathol (2006) 1.16
Do alloreactivity and prolonged cold ischemia cause different elementary lesions in chronic allograft nephropathy? Am J Pathol (2003) 1.02
Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation. Clin Exp Pharmacol Physiol (2007) 0.78
Activation of platelet-activating factor receptor exacerbates renal inflammation and promotes fibrosis. Lab Invest (2014) 0.77
The Effect of the Antioxidant Drug "U-74389G" on Creatinine Levels during Ischemia Reperfusion Injury in Rats. Curr Urol (2016) 0.75
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. J Med Chem (1998) 2.26
Prognostic factors in leukocytoclastic vasculitis: a clinicopathologic study of 160 patients. Arch Dermatol (1998) 2.17
Long-term results of biopsy-guided selection and allocation of kidneys from older donors in older recipients. Am J Transplant (2012) 2.17
Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res (2000) 2.12
Transcription factor-kappa B (NF-kappa B) and renal disease. Kidney Int (2001) 2.10
Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study. Clin Microbiol Infect (2014) 2.02
Partial splenic embolization for the treatment of hypersplenism in cirrhosis. Hepatology (1993) 1.95
Angiotensin II and renal fibrosis. Hypertension (2001) 1.87
HGF gene therapy attenuates renal allograft scarring by preventing the profibrotic inflammatory-induced mechanisms. Kidney Int (2006) 1.85
Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab Invest (1994) 1.84
Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage (2003) 1.79
IgA glomerulonephritis (Berger's disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol (1980) 1.75
Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature. AIDS (1991) 1.74
Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension (2001) 1.72
B-cell alloantigen Ag 7a in multiple sclerosis. Lancet (1975) 1.67
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect (2014) 1.61
Optimizing cadaveric organ procurement: the catalan and Spanish experience. Am J Transplant (2003) 1.58
Red wine intake prevents nuclear factor-kappaB activation in peripheral blood mononuclear cells of healthy volunteers during postprandial lipemia. Circulation (2000) 1.51
Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant (2006) 1.50
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure. Kidney Int (2001) 1.50
Protocol renal allograft biopsies and the design of clinical trials aimed to prevent or treat chronic allograft nephropathy. Transplantation (2000) 1.48
The PDGFRβ-AKT pathway contributes to CDDP-acquired resistance in testicular germ cell tumors. Clin Cancer Res (2013) 1.47
HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol (1998) 1.45
Losartan improves resistance artery lesions and prevents CTGF and TGF-beta production in mild hypertensive patients. Kidney Int (2006) 1.45
Oncogenic osteomalacia: case report and review of head and neck associated tumours. J Laryngol Otol (1998) 1.42
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from nitric oxide synthesis inhibition. Am J Physiol Renal Physiol (2001) 1.42
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol (1998) 1.41
[CD4+ lymphocytes in patients with a Leishmania-HIV coinfection]. Med Clin (Barc) (1995) 1.41
Synthesis and SAR of a new series of COX-2-selective inhibitors: pyrazolo[1,5-a]pyrimidines. J Med Chem (2001) 1.41
Mycophenolate mofetil in anti-MPO renal vasculitis: an alternative therapy in case of cyclophosphamide or azathioprine toxicity. Clin Nephrol (2008) 1.40
Insulin-like growth factor I - a novel biomarker of abdominal aortic aneurysms. Eur J Vasc Endovasc Surg (2011) 1.40
Familial IgA nephropathy associated with bilateral sensorineural deafness. Am J Kidney Dis (1992) 1.39
Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism. Immunopharmacology (1982) 1.39
Adenomyoepithelioma of the breast. A report of two cases. Arch Pathol Lab Med (1992) 1.38
[Fierce diagnosis and treatment]. Med Clin (Barc) (2001) 1.38
Nuclear IKK activity leads to dysregulated notch-dependent gene expression in colorectal cancer. Proc Natl Acad Sci U S A (2006) 1.36
Detection of monomeric and polymeric IgA containing immune complexes in serum and kidney from patients with alcoholic liver disease. Clin Exp Immunol (1982) 1.35
Cytokine cooperation in renal tubular cell injury: the role of TWEAK. Kidney Int (2006) 1.34
Immune complexes in IgA nephropathy: presence of antibodies against diet antigens and delayed clearance of specific polymeric IgA immune complexes. Clin Exp Immunol (1983) 1.34
Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis (1999) 1.34
T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathol (1983) 1.32
3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ Res (1998) 1.31
Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens (2001) 1.30
A possible common pathogenesis of the mesangial IgA glomerulonephritis in patients with Berger's disease and Schönlein-Henoch syndrome. Proc Eur Dial Transplant Assoc (1980) 1.26
HIV-1 genetic diversity in Galicia Spain: BG intersubtype recombinant viruses circulating among injecting drug users. AIDS (2001) 1.25
Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J Immunol (1994) 1.23
Histopathological correlation of cartilage swelling detected by magnetic resonance imaging in early experimental osteoarthritis. Osteoarthritis Cartilage (2004) 1.18
Expression of apoptosis regulatory proteins in tubular epithelium stressed in culture or following acute renal failure. Kidney Int (2000) 1.17
Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol (1982) 1.15
Acoustic analysis of snoring sound in patients with simple snoring and obstructive sleep apnoea. Eur Respir J (1996) 1.14
Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes. Am J Physiol Heart Circ Physiol (2009) 1.13
Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol (1984) 1.13
Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol (2000) 1.12
Potential role of nuclear factor κB in diabetic cardiomyopathy. Mediators Inflamm (2011) 1.12
Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int (2001) 1.12
Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol (2001) 1.12
High-resolution MRI detects cartilage swelling at the early stages of experimental osteoarthritis. Osteoarthritis Cartilage (2001) 1.11
Small cell carcinoma of the urinary bladder. Presentation of 23 cases and review of 134 published cases. Eur Urol (2001) 1.11
Cardiac hemangioma with papillary endothelial hyperplasia: report of a resected case and review of the literature. Ann Thorac Surg (1990) 1.10
Evidence for the involvement of IgE-basophil system in acute serum sickness. Clin Exp Immunol (1976) 1.10
Prevalence of and risk factors for pulmonary abnormalities in HIV-infected patients treated with antiretroviral therapy. HIV Med (2013) 1.10
When learning a second language does not mean losing the first: bilingual language development in low-income, Spanish-speaking children attending bilingual preschool. Child Dev (1999) 1.10
p27Kip1 represses transcription by direct interaction with p130/E2F4 at the promoters of target genes. Oncogene (2011) 1.09
Substituting walnuts for monounsaturated fat improves the serum lipid profile of hypercholesterolemic men and women. A randomized crossover trial. Ann Intern Med (2000) 1.09
Angiotensin II modulates cell growth-related events and synthesis of matrix proteins in renal interstitial fibroblasts. Kidney Int (1997) 1.08
Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int (2000) 1.08
Donor age and delayed graft function as predictors of renal allograft survival in rejection-free patients. Nephrol Dial Transplant (1999) 1.07
Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization. Br J Pharmacol (2012) 1.07
Vasoactive hormones and renal sclerosis. Kidney Int (1996) 1.07
Effects and interactions of endothelin-1 and angiotensin II on matrix protein expression and synthesis and mesangial cell growth. Hypertension (1996) 1.07
Totally laparoscopic right-lobe hepatectomy for adult living donor liver transplantation: useful strategies to enhance safety. Am J Transplant (2013) 1.07
Effect of endothelin-1 on neutrophil adhesion to endothelial cells and perfused heart. Circulation (1993) 1.06
Dynamic color Doppler sonography of intestinal wall in patients with Crohn disease compared with healthy subjects. J Pediatr Gastroenterol Nutr (2004) 1.06
HIV-1 infected patients older than 50 years. PISCIS cohort study. J Infect (2008) 1.04
Posterior urethral valves: prognostic factors. BJU Int (2003) 1.04
In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry. Kidney Int (1999) 1.04
Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: role of TGF-beta. J Immunol (1996) 1.04
A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma. Cancer Gene Ther (2010) 1.02
Early protocol renal allograft biopsies and graft outcome. Kidney Int (1997) 1.02
Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. Atherosclerosis (2002) 1.01
Angiotensin-converting enzyme is upregulated in the proximal tubules of rats with intense proteinuria. Hypertension (1999) 1.01
Immunomodulatory effect of mesenchymal stem cells on B cells. Front Immunol (2012) 1.01
Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia. Am J Physiol (1996) 1.01
Evidence for a specific IgA receptor in rat and human mesangial cells. J Immunol (1993) 1.00
Apoptotic cell death in renal injury: the rationale for intervention. Curr Drug Targets Immune Endocr Metabol Disord (2002) 1.00
Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest (1994) 1.00
Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency. Clin Pharmacol Ther (1999) 0.99
Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer. Curr Cancer Drug Targets (2009) 0.99
Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response. J Lipid Mediat (1990) 0.99
Targeting the voltage-dependent K(+) channels Kv1.3 and Kv1.5 as tumor biomarkers for cancer detection and prevention. Curr Med Chem (2012) 0.99